The new marketing authorization was granted on December 27 to Merck (MRK) Sharp & Dohme Limited ... market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks ...

In 2022, over 500 plaintiffs filed a case alleging that Merck Sharp & Dohme Corp., a drug manufacturing company, failed to provide adequate warnings that one of their drugs increased the risk of ...

Small Cell Lung Cancer Pipeline Insight 2025' report provides comprehensive global coverage of pipeline NSCLC therapies in ...

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

The American Chamber of Commerce in Vietnam has appointed doctor Dam Thi Hoang Lan, with decades of experience in healthcare, as its new chair.

Phase II trial evaluating efti in combination with radiotherapy plus KEYTRUDA® (pembrolizumab) in patients with soft tissue sarcoma reaches ...

The combination of belzutifan and cabozantinib has demonstrated “promising” antitumor activity in treatment-naive patients with advanced clear-cell RCC, according to researchers.

Then on Jan. 6, affiliated company WuXi Biologics said its subsidiary WuXi Vaccines plans to sell its vaccine plant in ...

EVX-01 is designed with Evaxion’s AI-Immunology™ platform and tailored to target the unique tumor profile and immune ...

Martin Grange, Trustee of Roy Castle Lung Cancer Foundation - and himself a lung cancer patient - also welcomed the news. He said: “Lung cancer takes up only 6% of the research funding spent on ...

Vaccination against COVID-19 reduces the incidence of hospitalization or death and the development of severe disease among ...